Neuroendocrine transformation of prostate adenocarcinoma with corpora cavernosa metastases.

RB1 loss genomics neuroendocrine prostate cancer neuroendocrine transformation small cell carcinoma

Journal

The Canadian journal of urology
ISSN: 1195-9479
Titre abrégé: Can J Urol
Pays: Canada
ID NLM: 9515842

Informations de publication

Date de publication:
12 2022
Historique:
entrez: 10 12 2022
pubmed: 11 12 2022
medline: 15 12 2022
Statut: ppublish

Résumé

We report the case of a 61-year-old male with metastatic prostate cancer who presented with urinary retention secondary to subdermal penile and corpora cavernosa metastases with neuroendocrine transformation of his metastatic hormone sensitive prostate cancer. We highlight the presentation, diagnosis, and management of this rare condition.

Identifiants

pubmed: 36495584

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

11399-11401

Auteurs

Halle Foss (H)

Department of Urology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.

Radhika Ragam (R)

Department of Urology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.

W Kevin Kelly (WK)

Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.

Leonard G Gomella (LG)

Department of Urology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH